Skip to main content
main-content

04-06-2018 | Prostate cancer | Video

Abi Race: abiraterone acetate and prednisone treatment in Black and White men with prostate cancer

Lead author Daniel George discusses his team's findings of a greater and longer lasting treatment effect with abiraterone acetate and prednisone in Black than White men with metastatic castration-resistance prostate cancer (3:59). 

Funding for this video was provided in part by F. Hoffmann-La Roche Ltd, Basel, Switzerland.

See the research in context now

with trial summaries, expert opinion and congress coverage

Image Credits